CENTA // Central Garden & Pet Company Nonvoting (Class A)
ANR <GO> NASDAQ RQD COCKPIT → CIK 0000887733 ↗ Consumer Discretionary • Consumer Specialties
$38.79 ▲ +0.48
(+1.25%)
MKT CAP: $2.43B • VOL: 327.0K
52W L $27 52W H $41
ROARABLE / RQD
B • 73/100
PIOTROSKI
8 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$33
MEDIAN
$43
MEAN
$44
HIGH
$53
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE CENTA TAPE
CENTA // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $46.94 | $44.61 | 2025-02-14 | $35.30 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $48.88 | $45.77 | 2025-02-06 | $36.46 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $44.22 | $42.67 | 2025-01-29 | $37.24 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $39.57 | — | 2025-01-17 | $38.01 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $34.14 | $36.85 | 2025-01-09 | $34.52 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $46.16 | $40.34 | 2024-12-18 | $33.75 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $37.63 | $39.18 | 2024-12-04 | $36.07 | -4.3% | 48% | C |